Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert Dubridge"'
Autor:
Robert Dubridge, Vanitha Ramakrishnan, David B. Powers, Debra T. Chao, Eric D. Hsi, Marjorie James, Marie Cardenas, Jennifer Grove, Ferdinand Evangelista, Melanie H.L. Wong, Roxanne Steinle, Mien Sho, Mian Su, Suzanne E. Ybarra, Pui Seto, Johnny Yin, Yongke Zhang, Donghee Choi, Patricia A. Culp
Supplementary Data from Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2604464c459cc7a933dbb26f10c6159f
https://doi.org/10.1158/1078-0432.22440232
https://doi.org/10.1158/1078-0432.22440232
Autor:
Robert Dubridge, Vanitha Ramakrishnan, David B. Powers, Debra T. Chao, Eric D. Hsi, Marjorie James, Marie Cardenas, Jennifer Grove, Ferdinand Evangelista, Melanie H.L. Wong, Roxanne Steinle, Mien Sho, Mian Su, Suzanne E. Ybarra, Pui Seto, Johnny Yin, Yongke Zhang, Donghee Choi, Patricia A. Culp
Purpose: Targeted therapeutics have significantly changed the outcome for patients diagnosed with cancer. Still, effective therapeutic intervention does not exist for many cancers and much remains to be done. The objective of this study was to identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c90a289cf91f77e4c3cc630c736c91
https://doi.org/10.1158/1078-0432.c.6517582
https://doi.org/10.1158/1078-0432.c.6517582
Autor:
Jessica Krakow, Michal Hammel, Ying Zhu, Brian J Hillier, Bryce Paolella, Austin Desmarais, Rusty Wall, Tseng-Hui T Chen, Rex Pei, Chulani Karunatilake, Robert DuBridge, Maia Vinogradova
Publikováno v:
Antib Ther
Background COBRA™ (COnditional Bispecific Redirected Activation) T-cell engagers are designed to target solid tumors as a single polypeptide chain prodrug that becomes activated by proteolysis in the tumor microenvironment. One COBRA molecule compr
Autor:
Keith S. Wilson, Sushmita Roy, Shanhua Lin, Cedric Wiesner, John C. Cheville, Robert A. Figlin, Karen L. Reckamp, Charles Hannum, Robert Dubridge, Jordan Hiller, Ted Jones, Christopher H. Becker
Publikováno v:
Proteomics. Clinical applications. 4(8-9)
Purpose: We investigated the ability to perform a clinical proteomic study using samples collected at different times from two independent clinical sites. Experimental Design: Label-free 2-D-LC-MS proteomic analysis was used to differentially quantif
Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits.
Autor:
Vinay Bhaskar, Melvin Fox, Danna Breinberg, Melanie Wong, Pauline Wales, Susan Rhodes, Robert DuBridge, Vanitha Ramakrishnan
Publikováno v:
Investigational New Drugs; Feb2008, Vol. 26 Issue 1, p7-12, 6p, 1 Color Photograph, 3 Graphs